Theravance Biopharma, Inc. reports

Company location: George Town, Grand Cayman, CA
Fiscal year end: 31 December

Theravance Biopharma, Inc. has filed 1,125 SEC EDGAR filings since 01 Aug 2013

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 401-425 of 1,000 matching filings.

Per page

25

Current page

17

SC 13G File 005-88552

SC 13G filing

Filing date: 27 Sep 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36033

FORM 8-K

Filing date: 15 Sep 2021
Reporting date: 15 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-88552

SCHEDULE 13G

Filing date: 07 Sep 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 Aug 2021
Reporting date: 20 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36033

FORM 8-K

Filing date: 23 Aug 2021
Reporting date: 23 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36033

10-Q

Filing date: 05 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36033

FORM 8-K

Filing date: 03 Aug 2021
Reporting date: 03 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36033

FORM 8-K

Filing date: 28 Jun 2021
Reporting date: 24 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

424B5 File 333-235339

424B5

Filing date: 25 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

424B5 File 333-235339

424B5

Filing date: 24 Jun 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36033

FORM 8-K

Filing date: 21 Jun 2021
Reporting date: 21 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 May 2021
Reporting date: 20 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 May 2021
Reporting date: 20 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 May 2021
Reporting date: 20 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 May 2021
Reporting date: 20 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 May 2021
Reporting date: 20 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 -

Filing date: 24 May 2021
Reporting date: 20 May 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .